TrialProstate cancer and prostatic diseases2022

The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).

Henry H Woo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.